Description
| Specialty | RIVA | 
|---|---|
| Dosage | 20 mg | 
| Form | Film-coated tablet | 
| Presentation | Box of 30 | 
| Primary Packaging | Blister | 
| Specification | ALU, PVC, PVDC | 
| INN (International Nonproprietary Name) | RIVAROXABAN | 
| VEIC Classification | Essential | 
| Therapeutic Class | BLOOD AND HEMATOPOIETIC ORGANS | 
| Sub-Class | ANTITHROMBOTIC AGENTS | 
| Laboratory | PHILADELPHIA PHARMA | 
| Schedule/Table | A | 
| Shelf Life | 24 (months) | 
| Generic/Brand Name (Princeps) | Generic | 
| Marketing Authorization Number (MA) | 9353256 | 
| Marketing Authorization Date | 2020-06-29 | 
| Product Range | Cardio-Metabolic Range | 







Reviews
There are no reviews yet.